Consistent with these findings, colocalization of phosphorylated Tau and PSD-95 increases during Alzheimer’s disease progression across clinically stratified groups (normal, mild cognitive impairment, Alzheimer’s disease) in the frontal cortex30. This evidence concerns the gene DLG4 and Alzheimer disease.